API attacks, particularly those involving shadow APIs, along with AI-driven attacks and supply chain vulnerabilities, are impacting cybersecurity. Companies like RayAegis are utilising AI to detect potential threats and vulnerabilities. However, with concerns over inadequate access controls and the successful bypassing of web application firewalls, organizations are struggling to prevent threats. RayAegis is pioneering AI-driven solutions to address evolving cybersecurity threats and mitigate risk.
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity
Bluebird Bio, a biotech company with three approved gene therapies but no way of commercialising them, will be sold to private equity firms Carlyle and
